Dr. Paul Sufka

Currently, there is very little data on the outcomes among patients with rheumatic diseases and patients treated with rheumatology medications who contract COVID-19. This secure, de-identified, international registry will curate and disseminate results from the submitted cases to address these knowledge gaps. Top goals of the registry include: 1. Understanding the outcomes of patients with...